The types segment classifies mangosteen extract by physical form and source material, influencing both processing costs and end‑use suitability. Powdered extracts, derived from freeze‑dried pericarp, dominate due to ease of incorporation into capsules, tablets, and dry food matrices, and they typically command the highest volume share. Liquid extracts, produced via ethanol or supercritical CO₂ extraction, are preferred in cosmetic formulations where solubility and rapid skin absorption are critical; they also enable precise dosing in nutraceutical beverages. Encapsulated formats, such as soft‑gel or micro‑encapsulated powders, address stability concerns by protecting xanthones from oxidation, thereby supporting premium pricing in functional food applications. Standardized extracts, defined by a minimum xanthone content (e.g., 30 % α‑mangostin), serve niche markets that require consistent bioactivity for clinical or regulatory compliance. Each subtype contributes uniquely to the market’s overall valuation by aligning production complexity with specific consumer and manufacturer requirements.